focus -WSS

focus

author：entertainment 2025-10-02 08:24:17 - browse：7979

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： UnitedHealth argues against case alleging wrongful AI care denials

focus

WSS

Too many hospitalized Covid

Latigo launches with $135 million for Vertex

Long Covid research funding gets a major boost from NIH

Having children helps parents live longer, especially after age 80

Investigation reveals sickle cell patients pressured into sterilizations

Study gives hint on South Asians’ higher risk of cardiovascular disease

focus

focus

focus

Guidelines to prevent youth baseball injuries need more muscle

Tome Biosciences co

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Reports of telehealth's death have been greatly exaggerated

At least 13 dead in Texas as scorching temps continue

Congress might make insulin pumps more accessible to the blind

As demand for Covid shots wanes, Moderna seeks its next success

Artificial intelligence use in health care faces greater scrutiny in 2024

Wildfire smoke exposes gaps in outdoor worker protections

Biogen joins immunology wave with $1.15 billion acquisition of HI

leisure time

H5N1 bird flu outbreak: Second human case reported, in Michigan

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Reports of telehealth's death have been greatly exaggerated

AMAs digital advisors table RPM coding reform proposal, again

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

focus

hotspot

focus

hotspot